Black Diamond Therapeutics, Inc. (BDTX)
2.395
-0.16
(-6.45%)
USD |
NASDAQ |
Jan 20, 16:00
2.40
0.00 (0.00%)
After-Hours: 19:11
Black Diamond Therapeutics Market Cap: 136.45M for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Emergent BioSolutions, Inc. | 582.97M |
| Johnson & Johnson | 525.64B |
| Puma Biotechnology, Inc. | 333.34M |
| Oric Pharmaceuticals, Inc. | 1.133B |
| NovaBay Pharmaceuticals, Inc. | 825.37M |
Market Cap Related Metrics
| PE Ratio | 6.601 |
| PS Ratio | 1.950 |
| Price to Book Value | 1.082 |
| Price to Free Cash Flow | 6.396 |
| Price | 2.395 |
| Earnings Yield | 15.15% |
| Operating PE Ratio | 11.51 |
| Normalized PE Ratio | 6.601 |